The Lux Lab is part of the Translational Research in Ultrasound Theranostics (TRUST) Program.
Our research interests lie in the development of novel platforms to diagnose and treat disease in vivo noninvasively.
Our group focuses on three main research topics:
- Ultrasound-guided immunotherapy of cancer
- Targeted and activatable ultrasound contrast agents
- Bioresponsive nanomaterials for in vivo detection of disease and therapy
Our long-term objective is to develop clinically translatable imaging agents and immunotherapeutics.